Cassava Sciences Stock Looks Ready To Break Out If This Pattern Is Confirmed
Cassava Sciences Inc. (NASDAQ: SAVA) shares were moving Monday after the company announced positive clinical data with SavaDx.
Cassava Sciences Highlights Data With SavaDx From A Randomized Controlled Phase 2b Study Of Simufilam
Cassava Sciences, Inc. (NASDAQ:SAVA) today announced positive clinical data with SavaDx, an investigational diagnostic/biomarker to detect Alzheimer's disease with a simple blood test. SavaDx was used to measure
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer’s Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start to the pharma reporting season.
An Unforgettable Week For Alzheimer’s Treatment Stocks: Two Of Our Recent Top Names Spike On News Of Potentially Promising Treatments
Screen capture via IGC's healthcare subsidiary Hyalolex. "Drops of Clarity" is their just-patented Alzheimer's treatment.
Two Stocks Spike On Alzheimer's News
Update On A Bear-Proof Portfolio: The Portfolio We Presented Earlier This Week Is Off To A Fast Start
Japanese gameshow contestant versus bear. Image via TMZ.
Bear-Proof Portfolio Update
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 22)
38 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares jumped 218.7% to $6.57 after the company received a $28.3 million purchase order from Brazil's Bio-Manguinhos to purchase Chembio's DPP SARS-CoV-2 Antigen tests for delivery during 2021.
Cassava Sciences to Present New Clinical Dataset at 2021 Alzheimer’s Association International Conference Jul. 26
- On Monday, July 26th, New Clinical Data for SavaDx to be Shared in
a Poster Presentation -
- On Thursday, July 29th, New Clinical Data for Simufilam to be Featured in a Podium Presentation -
AUSTIN, Texas, July 21,